Literature DB >> 23783103

In-depth characterization of the microRNA transcriptome in normal thyroid and papillary thyroid carcinoma.

Michal Swierniak1, Anna Wojcicka, Malgorzata Czetwertynska, Elzbieta Stachlewska, Monika Maciag, Wieslaw Wiechno, Barbara Gornicka, Magdalena Bogdanska, Lukasz Koperski, Albert de la Chapelle, Krystian Jazdzewski.   

Abstract

CONTEXT: A single microRNA gene may give rise to several mature products that differ in length, called isomiRs. IsomiRs are known to be tissue specific and functionally relevant. The microRNA sequence heterogeneity of the thyroid gland has yet to be determined.
OBJECTIVE: The objective of the study was to provide a comprehensive view of the microRNA transcriptome in normal thyroid and papillary thyroid carcinoma (PTC).
DESIGN: We used next-generation deep sequencing to analyze microRNA length heterogeneity and expression profiles of PTC tumors (n = 14), unaffected tissue adjacent to tumors (n = 14), and control, noncancerous thyroid tissue (n = 14). The results were validated with a microarray on an additional set of 9 PTC tumor/normal tissue pairs.
RESULTS: Eighty-nine microRNAs were significantly deregulated in PTC compared with normal thyroid tissue (false discovery rate < 0.05, fold change 0.13-20.7). Top deregulated miRNAs included miR-146b-5p, miR-221-3p, miR-7-3p, miR-551b-3p, miR-486-3p, and miR-144-3p, confirming previous microarray profiling. The expression of miRNAs did not depend on the BRAF mutation status. Interestingly, 85% of the most abundant microRNAs consisted of isoforms that differed from the standard reference sequence deposited in miRBase. Moreover, the reference microRNAs were completely absent in 42.4% and 35.9% of the microRNAs expressed in normal thyroid and PTC tumors, respectively. Numerous isomiRs had altered seed sequences, which led to a different set of target genes. For highly deregulated miR-146b-5p, we detected 6 isoforms (tumor/normal fold change 14.4-28.7, false discovery rate < 0.002) that varied at their 5' ends with a 1-nt difference that created 2 alternative seeds. The target genes for those 2 seeds overlapped in only 13.1% of genes.
CONCLUSIONS: Almost all microRNAs exhibit isoforms of variable length and potentially distinct function in thyroid tumorigenesis.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23783103      PMCID: PMC5399477          DOI: 10.1210/jc.2013-1214

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  36 in total

1.  Distinct pattern of ret oncogene rearrangements in morphological variants of radiation-induced and sporadic thyroid papillary carcinomas in children.

Authors:  Y E Nikiforov; J M Rowland; K E Bove; H Monforte-Munoz; J A Fagin
Journal:  Cancer Res       Date:  1997-05-01       Impact factor: 12.701

2.  Structural basis for 5'-nucleotide base-specific recognition of guide RNA by human AGO2.

Authors:  Filipp Frank; Nahum Sonenberg; Bhushan Nagar
Journal:  Nature       Date:  2010-05-26       Impact factor: 49.962

Review 3.  The genetic epidemiology of cancer: interpreting family and twin studies and their implications for molecular genetic approaches.

Authors:  N Risch
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2001-07       Impact factor: 4.254

Review 4.  miRBase: the microRNA sequence database.

Authors:  Sam Griffiths-Jones
Journal:  Methods Mol Biol       Date:  2006

5.  Determinants of targeting by endogenous and exogenous microRNAs and siRNAs.

Authors:  Cydney B Nielsen; Noam Shomron; Rickard Sandberg; Eran Hornstein; Jacob Kitzman; Christopher B Burge
Journal:  RNA       Date:  2007-09-13       Impact factor: 4.942

6.  Application of massively parallel sequencing to microRNA profiling and discovery in human embryonic stem cells.

Authors:  Ryan D Morin; Michael D O'Connor; Malachi Griffith; Florian Kuchenbauer; Allen Delaney; Anna-Liisa Prabhu; Yongjun Zhao; Helen McDonald; Thomas Zeng; Martin Hirst; Connie J Eaves; Marco A Marra
Journal:  Genome Res       Date:  2008-02-19       Impact factor: 9.043

7.  The role of microRNA genes in papillary thyroid carcinoma.

Authors:  Huiling He; Krystian Jazdzewski; Wei Li; Sandya Liyanarachchi; Rebecca Nagy; Stefano Volinia; George A Calin; Chang-Gong Liu; Kaarle Franssila; Saul Suster; Richard T Kloos; Carlo M Croce; Albert de la Chapelle
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-19       Impact factor: 11.205

8.  Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs.

Authors:  Lee P Lim; Nelson C Lau; Philip Garrett-Engele; Andrew Grimson; Janell M Schelter; John Castle; David P Bartel; Peter S Linsley; Jason M Johnson
Journal:  Nature       Date:  2005-01-30       Impact factor: 49.962

9.  The polymorphism rs944289 predisposes to papillary thyroid carcinoma through a large intergenic noncoding RNA gene of tumor suppressor type.

Authors:  Jaroslaw Jendrzejewski; Huiling He; Hanna S Radomska; Wei Li; Jerneja Tomsic; Sandya Liyanarachchi; Ramana V Davuluri; Rebecca Nagy; Albert de la Chapelle
Journal:  Proc Natl Acad Sci U S A       Date:  2012-05-14       Impact factor: 11.205

10.  Common variants on 9q22.33 and 14q13.3 predispose to thyroid cancer in European populations.

Authors:  Julius Gudmundsson; Patrick Sulem; Daniel F Gudbjartsson; Jon G Jonasson; Asgeir Sigurdsson; Jon T Bergthorsson; Huiling He; Thorarinn Blondal; Frank Geller; Margret Jakobsdottir; Droplaug N Magnusdottir; Sigurborg Matthiasdottir; Simon N Stacey; Oskar B Skarphedinsson; Hafdis Helgadottir; Wei Li; Rebecca Nagy; Esperanza Aguillo; Eduardo Faure; Enrique Prats; Berta Saez; Mariano Martinez; Gudmundur I Eyjolfsson; Unnur S Bjornsdottir; Hilma Holm; Kristleifur Kristjansson; Michael L Frigge; Hoskuldur Kristvinsson; Jeffrey R Gulcher; Thorvaldur Jonsson; Thorunn Rafnar; Hannes Hjartarsson; Jose I Mayordomo; Albert de la Chapelle; Jon Hrafnkelsson; Unnur Thorsteinsdottir; Augustine Kong; Kari Stefansson
Journal:  Nat Genet       Date:  2009-02-06       Impact factor: 38.330

View more
  61 in total

1.  Promoter methylation of p16 and RASSF1A genes may contribute to the risk of papillary thyroid cancer: A meta-analysis.

Authors:  Jia-Li Jiang; Gui-Lan Tian; Shu-Jiao Chen; L I Xu; Hui-Qin Wang
Journal:  Exp Ther Med       Date:  2015-07-24       Impact factor: 2.447

2.  Identification of down-regulated microRNAs in thyroid cancer and their potential functions.

Authors:  Denghua Pan; Peng Lin; Dongyue Wen; Yunpeng Wei; Qiuyan Mo; Liang Liang; Gang Chen; Yun He; Junqiang Chen; Hong Yang
Journal:  Am J Transl Res       Date:  2018-08-15       Impact factor: 4.060

3.  Plasma exosomal miR-21 and miR-181a differentiates follicular from papillary thyroid cancer.

Authors:  Roman Samsonov; Vladimir Burdakov; Tatiana Shtam; Zamira Radzhabovа; Dmitry Vasilyev; Evgenia Tsyrlina; Sergey Titov; Michail Ivanov; Lev Berstein; Michael Filatov; Nikolay Kolesnikov; Hava Gil-Henn; Anastasia Malek
Journal:  Tumour Biol       Date:  2016-05-11

4.  MicroRNA deep-sequencing reveals master regulators of follicular and papillary thyroid tumors.

Authors:  Veronika Mancikova; Esmeralda Castelblanco; Elena Pineiro-Yanez; Javier Perales-Paton; Aguirre A de Cubas; Lucia Inglada-Perez; Xavier Matias-Guiu; Ismael Capel; Maria Bella; Enrique Lerma; Garcilaso Riesco-Eizaguirre; Pilar Santisteban; Francisco Maravall; Didac Mauricio; Fatima Al-Shahrour; Mercedes Robledo
Journal:  Mod Pathol       Date:  2015-02-27       Impact factor: 7.842

5.  Distribution of miRNA expression across human tissues.

Authors:  Nicole Ludwig; Petra Leidinger; Kurt Becker; Christina Backes; Tobias Fehlmann; Christian Pallasch; Steffi Rheinheimer; Benjamin Meder; Cord Stähler; Eckart Meese; Andreas Keller
Journal:  Nucleic Acids Res       Date:  2016-02-25       Impact factor: 16.971

6.  Two-miRNA classifiers differentiate mutation-negative follicular thyroid carcinomas and follicular thyroid adenomas in fine needle aspirations with high specificity.

Authors:  Tomasz Stokowy; Bartosz Wojtas; Barbara Jarzab; Knut Krohn; David Fredman; Henning Dralle; Thomas Musholt; Steffen Hauptmann; Dariusz Lange; László Hegedüs; Ralf Paschke; Markus Eszlinger
Journal:  Endocrine       Date:  2016-07-29       Impact factor: 3.633

7.  microRNA-339-5p modulates Na+/I- symporter-mediated radioiodide uptake.

Authors:  Aparna Lakshmanan; Anna Wojcicka; Marta Kotlarek; Xiaoli Zhang; Krystian Jazdzewski; Sissy M Jhiang
Journal:  Endocr Relat Cancer       Date:  2014-11-17       Impact factor: 5.678

8.  Relationship between VEGF protein expression and lymph node metastasis in papillary thyroid carcinoma among Asians: a meta-analysis.

Authors:  De-Feng Chang; Zhong-Qing Xu; Bin Sun
Journal:  Tumour Biol       Date:  2014-02-21

9.  Comprehensive gene and microRNA expression profiling reveals a role for miRNAs in the oncogenic roles of SphK1 in papillary thyroid cancer.

Authors:  Weiwei Liang; Zhiwei Xie; Weiling Cui; Yan Guo; Lijuan Xu; Jueheng Wu; Hongyu Guan
Journal:  J Cancer Res Clin Oncol       Date:  2016-12-10       Impact factor: 4.553

10.  Down-regulation of miR-144 promotes thyroid cancer cell invasion by targeting ZEB1 and ZEB2.

Authors:  Hongyu Guan; Weiwei Liang; Zhiwei Xie; Hai Li; Juan Liu; Liehua Liu; Lingling Xiu; Yanbing Li
Journal:  Endocrine       Date:  2014-06-27       Impact factor: 3.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.